Buprenorphine and Naloxone 2mg/0.5mg combination research material from Raw Lab Chems
Suboxone 2mg Price range: € 299,00 through € 649,00
Back to products
Fluclotizolam Pellets thienotriazolodiazepine research material from Raw Lab Chems
Fluclotizolam 0.5mg Pellets Price range: € 150,00 through € 990,00

Buy Clonazolam

Price range: € 57,00 through € 209,00

Clonazolam Pellets are described as a laboratory research preparation containing clonazolam, also known as clonitrazolam, a synthetic nitro-substituted triazolobenzodiazepine structurally related to clonazepam.

Raw Lab Chems identifies this material exclusively within the context of controlled chemical identification, forensic analytical characterization, chromatographic investigation, and benzodiazepine reference comparisons.

The supplied information includes claims concerning ingredient purity, independent testing, content consistency, and specialized storage and packaging. No Raw Lab Chems batch-specific analytical records were provided to verify these specifications.

The labeled pellet content should be distinguished from independently established content uniformity or certified reference-material status.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-13205 Category:
Description

Clonazolam Pellets 1mg – Triazolobenzodiazepine Research Material

Product Overview

Clonazolam Pellets are described in the supplied information as a laboratory research preparation associated with clonazolam, also known as clonitrazolam.

Clonazolam belongs to the triazolobenzodiazepine family and is structurally related to clonazepam and other substituted benzodiazepines.

The compound is of interest in forensic analytical chemistry because its molecular structure can be distinguished from those of related benzodiazepine derivatives through appropriate chemical identification methods.

Raw Lab Chems presents this material exclusively within a Research Use Only framework.

The supplied source describes a compressed pellet presentation intended for controlled laboratory investigation.

However, the stated presentation does not independently establish the actual chemical identity, purity, finished-unit composition, or content uniformity.

The source also contains claims concerning third-party testing, controlled manufacturing, cold-chain storage, and consistent analytical quality.

These statements originated in material referencing another supplier and cannot be attributed to Raw Lab Chems without independent documentation.

No clinical, therapeutic, diagnostic, dietary, or consumer-oriented application is represented by this description.

Chemical Identity & Classification

Clonazolam is a synthetic compound belonging to the triazolobenzodiazepine chemical family.

It is also referred to as clonitrazolam and is structurally associated with nitro-substituted benzodiazepine derivatives.

The supplied source provides the following chemical-reference information:

  • Common name: Clonazolam
  • Alternative name: Clonitrazolam
  • Chemical classification: Nitro-substituted triazolobenzodiazepine
  • Reported systematic name: 6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
  • Reported molecular formula: C17H12ClN5O2
  • Reported molecular weight: 353.76 g/mol
  • CAS Registry Number: Not supplied in the source

These identifiers are reproduced from the supplied information and do not independently verify the composition of the actual product.

The reported molecular formula and molecular weight are arithmetically consistent with one another.

However, consistency between a formula and calculated mass does not establish that the actual pellet ingredient has been independently identified.

The source does not provide a verified salt-form designation or complete formulation specification.

This distinction matters because the composition of the finished preparation may differ from the molecular formula of the named active chemical.

Researchers seeking public chemical-reference information may consult PubChem and confirm that any selected database entry corresponds to the intended compound and chemical form.

Chemical & Physical Characteristics

The supplied product is described as compressed pellets containing clonazolam.

No product-specific inspection report, pellet-dimension specification, excipient list, or formulation-characterization record was provided.

The stated physical presentation therefore remains a source-provided description.

The clonazolam molecular framework contains a fused triazole-benzodiazepine ring system and substituents that distinguish it from other benzodiazepine compounds.

These structural features provide a basis for analytical differentiation through chromatographic and spectroscopic techniques.

However, structural similarity does not establish identical physical properties, stability, impurity profiles, or analytical behavior.

No verified melting point, quantitative solubility profile, particle-size distribution, crystalline polymorph, density, or hygroscopicity measurement was supplied.

The characteristics of the finished pellet may also depend on formulation ingredients that were not identified in the source.

The supplied text recommends dry, dark storage under controlled temperature conditions.

No validated stability study, degradation profile, or experimentally established shelf-life specification accompanied this recommendation.

Researchers should distinguish general storage guidance from verified stability data associated with a particular batch.

Purity & Analytical Verification

The supplied description claims ingredient purity of at least 98% and references independent quality-control testing.

However, no actual Raw Lab Chems batch-specific Certificate of Analysis, chromatogram, mass spectrum, NMR spectrum, or independent laboratory report was provided.

Accordingly, the stated purity threshold is not independently confirmed for the material described here.

The source identifies chromatographic purity profiling and forensic analytical detection as relevant areas of investigation.

HPLC, GC-MS, and LC-MS/MS are among the analytical techniques used in research involving benzodiazepine identification and differentiation.

Such methods may provide information concerning chemical identity, structural characteristics, impurity profiles, and analytical specificity.

However, naming an analytical technique does not establish that it was performed on the actual product.

An important distinction exists between ingredient purity and the composition of a finished pellet.

Even if the purity of a chemical ingredient were independently established, that result would not by itself confirm the labeled content, total formulation, or consistency between individual units.

The supplied source also refers to clonazolam-related metabolites and forensic toxicology research.

These references provide analytical context rather than evidence of the product’s verified performance in a particular laboratory method.

No certified reference-material status, validated finished-unit content, or independently established purity specification is asserted.

Quality Control & Batch Integrity

The supplied source claims that batches undergo independent testing and are supported by Certificates of Analysis.

It also describes analytical purity profiles, consistent pellet content, controlled storage, and specialized packaging.

No actual certificate, independent testing record, manufacturing audit, laboratory accreditation document, or batch-specific quality-control report accompanied these statements.

They therefore remain unverified claims.

Furthermore, the source refers to a supplier other than Raw Lab Chems.

Its quality-control representations should not be transferred to a Raw Lab Chems product listing without supporting documentation from the relevant supplier.

For reproducible laboratory investigation, useful records may include supplier identification, batch number, chemical identifier, receipt date, storage history, and available analytical findings.

For pellet preparations, the identity and purity of the named ingredient should be distinguished from the composition and consistency of the finished units.  Clonazolam Pellets

The supplied information does not establish independently verified content uniformity, excipient composition, or quantitative accuracy of the labeled amount.

Where a material is described as suitable for reference-standard work, researchers should distinguish ordinary catalog material from a certified reference material.

The supplied information does not establish certified reference-material status, metrological traceability, or an assigned measurement uncertainty.

Safety, Handling & Laboratory Precautions

Clonazolam is a benzodiazepine-related compound that requires appropriate institutional risk assessment and controlled laboratory handling.

Research personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.

Laboratory precautions should address access restrictions, protective equipment, contamination prevention, accidental exposure, environmental release, and chemical-waste disposal.

The compound’s structural relationship to other benzodiazepines does not establish safety for human or veterinary exposure.    Clonazolam Pellets

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Because the actual purity and pellet composition have not been independently confirmed, laboratory documentation should distinguish verified characteristics from source-provided statements.

The pellet presentation must not be interpreted as evidence of pharmaceutical suitability or authorization for personal use.

Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.

Packaging, Labeling & Storage

The supplied source describes double-sealed packaging, temperature-controlled logistics, and tracking during transportation.

No Raw Lab Chems packaging-validation study, verified container specification, shipment-condition record, or carrier documentation accompanied these claims.

The source recommends storage in a dry, dark environment under controlled temperature conditions.    Clonazolam Pellets

No validated stability data was provided to establish a specific temperature range or product-specific shelf life.

Claims concerning cold-chain storage and transport therefore remain unverified.

Laboratory inventory records should preserve the compound name, any available batch identifier, receipt details, and relevant storage observations.

The labeled pellet content should be recorded as a source-provided specification unless independently confirmed.  Clonazolam Pellets

Where chemical form or formulation ingredients remain uncertain, the inventory record should preserve those uncertainties rather than assign unverified details.

Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional laboratory procedures.

Intended Research Use & Market Positioning

The supplied scientific context places clonazolam within analytical research involving triazolobenzodiazepine derivatives, chemical identification, structural comparison, and forensic toxicology.

Its substituted molecular framework provides a basis for differentiating it from other benzodiazepine-related compounds in appropriately validated analytical investigations.

The source references chromatographic identification, mass-spectrometric characterization, and investigation of benzodiazepine-related analytical markers.

These references describe laboratory research contexts and do not establish any human-use application.

For comparative chemical-catalog context, Raw Lab Chems also lists Pyrazolam Pellets and Blue Xanax Bars B707.

These listings identify other named products but do not establish equivalent chemical identity, composition, purity, regulatory status, or analytical characteristics.

The supplied Clonazolam catalog reference identifies the product page associated with the material discussed here.

These references provide catalog context rather than evidence of certified reference-material status or interchangeability.

Ordering, Availability & Fulfillment

The supplied source includes claims concerning available pack sizes, European shipping coverage, same-day dispatch, delivery time frames, carrier services, and payment options.

However, those statements reference another supplier and are not verified Raw Lab Chems fulfillment specifications. Clonazolam Pellets

No current Raw Lab Chems inventory record, shipping schedule, destination-specific authorization, or carrier documentation was supplied.

Consequently, no particular availability, delivery period, shipping cost, customs-clearance arrangement, or transportation-compliance guarantee is asserted.

Clonazolam may be subject to strict controlled-substance legislation.

Institutional acquisition and transfer should therefore be assessed against the applicable laws governing the exact substance and chemical form involved.

Researchers and institutions should independently verify whether possession, importation, exportation, transportation, and laboratory investigation are authorized in their jurisdictions.

Research-only labeling does not establish an exemption from controlled-substance regulations.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Clonazolam is a triazolobenzodiazepine whose acquisition, possession, transfer, importation, exportation, storage, and laboratory investigation may be restricted or prohibited under applicable controlled-substance or other chemical regulations.  Clonazolam Pellets

The supplied source identifies clonazolam as a controlled substance in the United States, but its exact current scheduling status and jurisdiction-specific requirements were not independently verified for this listing.

Researchers and institutions remain responsible for determining the applicable legal classification and obtaining any necessary authorizations.

No medical approval, consumer-use authorization, universal legal status, or regulatory exemption is implied by this description.

Additional information
Quantity

30 pellets

,

60 pellets

,

90 pellets

,

120 pellets

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy Clonazolam”
Shipping & Delivery